John Burns
Finanzdirektor/CFO bei SELLAS LIFE SCIENCES GROUP, INC.
Vermögen: 39 368 $ am 30.04.2024
Aktive Positionen von John Burns
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SELLAS LIFE SCIENCES GROUP, INC. | Comptroller/Controller/Auditor | 30.12.2017 | - |
| Finanzdirektor/CFO | 30.12.2017 | - |
Karriereverlauf von John Burns
Ehemalige bekannte Positionen von John Burns
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| PIXELWORKS, INC. | Corporate Officer/Principal | - | - |
Galena Biopharma, Inc.
 Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Comptroller/Controller/Auditor | 23.02.2016 | - |
Ausbildung von John Burns
| Tulane University (Louisiana) | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Comptroller/Controller/Auditor | 2 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
| Electronic Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| PIXELWORKS, INC. | Electronic Technology |
| SELLAS LIFE SCIENCES GROUP, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Galena Biopharma, Inc.
Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Health Technology |
- Börse
- Insiders
- John Burns
- Erfahrung
